Patent · 2022 · pending
Treatment of MS4A4E Related Diseases and Disorders
MS4A4E inhibitors, including siRNA and antisense oligonucleotides, for conditions associated with MS4A4E mutations.
- Filings
- 1
- Status
- Pending
- First priority
- Jun 17, 2022
Patent · 2022 · pending
MS4A4E inhibitors, including siRNA and antisense oligonucleotides, for conditions associated with MS4A4E mutations.